Annual ROE
-141.57%
-76.05%-116.07%
December 31, 2023
Summary
- As of February 12, 2025, GANX annual return on equity is -141.57%, with the most recent change of -76.05% (-116.07%) on December 31, 2023.
- During the last 3 years, GANX annual ROE has fallen by -17.17% (-13.80%).
- GANX annual ROE is now -129.04% below its all-time high of 487.53%, reached on December 31, 2019.
Performance
GANX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-203.91%
+10.29%+4.80%
September 30, 2024
Summary
- As of February 12, 2025, GANX quarterly return on equity is -203.91%, with the most recent change of +10.29% (+4.80%) on September 30, 2024.
- Over the past year, GANX quarterly ROE has dropped by -10.87% (-5.63%).
- GANX quarterly ROE is now -848.86% below its all-time high of -21.49%, reached on March 31, 2021.
Performance
GANX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
GANX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -116.1% | -5.6% |
| 3 y3 years | -13.8% | -382.7% |
| 5 y5 years | - | -382.7% |
GANX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -116.1% | at low | -426.8% | +4.8% |
| 5 y | 5-year | -129.0% | at low | -848.9% | +4.8% |
| alltime | all time | -129.0% | at low | -848.9% | +4.8% |
Gain Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -203.91%(-4.8%) |
| Jun 2024 | - | -214.20%(+0.4%) |
| Mar 2024 | - | -213.34%(+10.5%) |
| Dec 2023 | -141.57%(+116.1%) | -193.04%(+13.9%) |
| Sep 2023 | - | -169.47%(+30.2%) |
| Jun 2023 | - | -130.19%(+54.6%) |
| Mar 2023 | - | -84.20%(+29.4%) |
| Dec 2022 | -65.52% | -65.05%(+24.1%) |
| Sep 2022 | - | -52.43%(+11.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | -47.05%(+21.5%) |
| Mar 2022 | - | -38.71%(-8.4%) |
| Dec 2021 | -67.73%(-45.6%) | - |
| Dec 2021 | - | -42.24%(+11.0%) |
| Sep 2021 | - | -38.04%(+38.0%) |
| Jun 2021 | - | -27.56%(+28.2%) |
| Mar 2021 | - | -21.49%(-62.7%) |
| Dec 2020 | -124.40%(-125.5%) | - |
| Dec 2020 | - | -57.69% |
| Dec 2019 | 487.53% | - |
FAQ
- What is Gain Therapeutics annual return on equity?
- What is the all time high annual ROE for Gain Therapeutics?
- What is Gain Therapeutics annual ROE year-on-year change?
- What is Gain Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Gain Therapeutics?
- What is Gain Therapeutics quarterly ROE year-on-year change?
What is Gain Therapeutics annual return on equity?
The current annual ROE of GANX is -141.57%
What is the all time high annual ROE for Gain Therapeutics?
Gain Therapeutics all-time high annual return on equity is 487.53%
What is Gain Therapeutics annual ROE year-on-year change?
Over the past year, GANX annual return on equity has changed by -76.05% (-116.07%)
What is Gain Therapeutics quarterly return on equity?
The current quarterly ROE of GANX is -203.91%
What is the all time high quarterly ROE for Gain Therapeutics?
Gain Therapeutics all-time high quarterly return on equity is -21.49%
What is Gain Therapeutics quarterly ROE year-on-year change?
Over the past year, GANX quarterly return on equity has changed by -10.87% (-5.63%)